drugset / Trial / NCT04843540
Drug-drug Interaction Study of CTP-543 and Rifampin in Healthy Adult Subjects
NaSequentialOpen-labelOther
Summary
This is a Phase 1 open-label study of the effect of rifampin on the pharmacokinetics of CTP-543 in healthy subjects.
Timeline
- Start
- 2021-05-19
- Primary completion
- 2021-06-24
- Completion
- 2021-07-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CTP-543 | Unknown | — | Oral |
| Subject | Rifampicin | Small molecule | — | Oral |
Indications
No indication recorded.